Microglial lipid droplets as therapeutic targets in age-related neurodegenerative diseases
{{output}}
Monoclonal antibodies approved for Alzheimer's disease (AD), such as lecanemab and aducanumab, have been shown to enhance microglial phagocytic function, underscoring the therapeutic relevance of microglia in neurodegenerative diseases (NDDs). Emerging eviden... ...
